IBOV 169,277.30 ▼ 0.32% IPC MEX 70,388.96 ▼ 1.15% MERVAL 2,848,945 — — USD/BRL5.82▲ 0.71% USD/MXN18.68▲ 1.41% USD/CLP1,006▲ 1.28% USD/COP3,330▲ 0.37% USD/PEN3.41▲ 0.05% USD/ARS1,558▲ 0.34% USD/UYU40.61▲ 3.30% USD/PYG6,212▲ 3.32% USD/BOB11.64▲ 3.07% USD/DOP60.14▼ 0.27% USD/CRC441.73▲ 2.50% USD/GTQ7.64▲ 3.28% USD/HNL26.89▼ 0.10% USD/NIO36.62▲ 0.34% USD/VES913.46▼ 0.22% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.39▲ 2.57% USD/TTD6.70▲ 1.98% EUR/BRL6.38▲ 0.47% BRENT 89.31 ▼ 4.11% WTI 83.26 ▼ 3.20% IRON ORE 161.91 — — COPPER 5.64 ▼ 5.62% GOLD 3,757 ▼ 2.77% SILVER 45.02 ▼ 4.81% SOY 1,217 ▼ 0.69% CORN 441.75 ▼ 1.12% WHEAT 596.75 ▲ 0.25% COFFEE 275.65 ▼ 3.82% SUGAR 18.25 ▲ 0.44% ORANGE JUICE 130.80 ▼ 3.11% COTTON 80.95 ▲ 4.69% COCOA 5,068 ▲ 0.76% BEEF 219.15 ▲ 0.17% CATTLE 336.35 ▲ 0.23% LITHIUM 55.52 ▼ 1.60% PETR4 43.40 ▼ 1.32% VALE3 59.20 ▼ 1.89% ITUB4 40.42 ▼ 1.15% BBDC4 14.28 ▼ 0.90% ABEV3 16.01 ▲ 0.50% BBAS3 14.26 ▼ 2.46% B3SA3 14.27 ▼ 2.59% WEGE3 51.94 ▲ 1.54% PRIO3 62.78 ▼ 1.84% SUZB3 55.58 ▲ 0.34% RENT3 29.81 ▲ 0.51% AZZA3 16.49 ▲ 5.43% CSAN3 3.24 ▼ 0.31% RAIZ4 18.49 ▼ 3.24% PCAR3 3.07 ▲ 6.23% GMAT3 4.21 ▲ 0.72% PSSA3 45.32 ▼ 1.31% CVCB3 0.77 ▼ 1.28% POSI3 3.22 ▲ 2.88% SLCE3 18.11 ▲ 0.28% NATU3 4.88 ▲ 2.74% BRKM5 2.61 ▼ 5.09% RANI3 8.13 ▼ 1.09% CSNA3 3.84 ▲ 1.86% IBOV 169,277.30 ▼ 0.32% IPC MEX 70,388.96 ▼ 1.15% MERVAL 2,848,945 — — USD/BRL 5.81 ▲ 0.53% USD/MXN 18.64 ▲ 1.21% USD/CLP 1,001 ▲ 0.77% USD/COP 3,308 ▼ 0.28% USD/PEN 3.41 ▲ 0.05% USD/ARS 1,558 ▲ 0.34% USD/UYU 40.61 ▲ 3.30% USD/PYG 6,212 ▲ 3.32% USD/BOB 11.64 ▲ 3.07% USD/DOP 60.14 ▼ 0.27% USD/CRC 441.73 ▲ 2.50% USD/GTQ 7.64 ▲ 3.28% USD/HNL 26.89 ▼ 0.10% USD/NIO 36.62 ▲ 0.34% USD/VES 913.46 ▼ 0.22% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.39 ▲ 2.57% USD/TTD 6.70 ▲ 1.98% EUR/BRL 6.37 ▲ 0.30% BRENT 89.31 ▼ 4.11% WTI 83.26 ▼ 3.20% IRON ORE 161.91 — — COPPER 5.64 ▼ 5.62% GOLD 3,757 ▼ 2.77% SILVER 45.02 ▼ 4.81% SOY 1,217 ▼ 0.69% CORN 441.75 ▼ 1.12% WHEAT 596.75 ▲ 0.25% COFFEE 275.65 ▼ 3.82% SUGAR 18.25 ▲ 0.44% ORANGE JUICE 130.80 ▼ 3.11% COTTON 80.95 ▲ 4.69% COCOA 5,068 ▲ 0.76% BEEF 219.15 ▲ 0.17% CATTLE 336.35 ▲ 0.23% LITHIUM 55.52 ▼ 1.60% PETR4 43.40 ▼ 1.32% VALE3 59.20 ▼ 1.89% ITUB4 40.42 ▼ 1.15% BBDC4 14.28 ▼ 0.90% ABEV3 16.01 ▲ 0.50% BBAS3 14.26 ▼ 2.46% B3SA3 14.27 ▼ 2.59% WEGE3 51.94 ▲ 1.54% PRIO3 62.78 ▼ 1.84% SUZB3 55.58 ▲ 0.34% RENT3 29.81 ▲ 0.51% AZZA3 16.49 ▲ 5.43% CSAN3 3.24 ▼ 0.31% RAIZ4 18.49 ▼ 3.24% PCAR3 3.07 ▲ 6.23% GMAT3 4.21 ▲ 0.72% PSSA3 45.32 ▼ 1.31% CVCB3 0.77 ▼ 1.28% POSI3 3.22 ▲ 2.88% SLCE3 18.11 ▲ 0.28% NATU3 4.88 ▲ 2.74% BRKM5 2.61 ▼ 5.09% RANI3 8.13 ▼ 1.09% CSNA3 3.84 ▲ 1.86%
since 2009
Wednesday, November 18, 2026

Covid-19 Brazil

Stem cells needed for domestic production of AstraZeneca vaccine arrive in Brazil

By · · 2 min read

RIO DE JANEIRO, BRAZIL – The stem cell and virus banks that will allow the vaccine developed by the Anglo-Swedish laboratory AstraZeneca to be produced locally and with total autonomy in Brazil arrived this Wednesday, June 2, in Rio de Janeiro, the Oswaldo Cruz Foundation (Fiocruz) has advised.

The material – which allows the creation of the active pharmaceutical ingredient (API), a biological component considered the “heart” of the vaccine – arrived in Brazil just one day after the transfer of technology for the manufacture of the raw materials to Fiocruz was confirmed, thus giving the country total autonomy for the manufacture of the vaccine.

Stem Cells.
Stem Cells.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Fiocruz, the main medical research center in Latin America, has been producing the AstraZeneca vaccine in Brazil, but with API imported from other countries, especially China.

The high demand for immunizers due to the pandemic has delayed the deliveries to Brazil, which has twice had to paralyze twice the production of vaccines due to the lack of APIs.

According to Fiocruz, API production will start this month in Rio de Janeiro; however, the first vaccines produced 100% in Brazil will only be ready in October, since a series of stages and tests are required for the first batches and the approval of the National Health Regulatory Agency (ANVISA) until full-scale production.

The Bio-manguinhos campus, where the vaccine will be manufactured in Rio, has the capacity to produce API for about 15 million doses of vaccine per month.

According to vaccination data from the Ministry of Health, out of 212 million Brazilians, only 22 million have received the two necessary doses, while another 45.2 million have received only the first dose.

Also, according to the Government, about 30% of the vaccines applied in the country are those developed by AstraZéneca, while 65% are from the Chinese firm Sinovac, packaged locally by the Butantan Institute of Sao Paulo, while the rest are from the U.S. pharmaceutical company Pfizer.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.